"NAME";"PROBE";"GENE SYMBOL";"GENE TITLE";"RANK IN GENE LIST";"RANK METRIC SCORE";"CORE ENRICHMENT"
"row_0";"ENSG00000012223";"LTF";"lactotransferrin";1757;9,31097888946533;"No"
"row_1";"ENSG00000134321";"RSAD2";"radical S-adenosyl methionine domain containing 2";2243;6,18826913833618;"No"
"row_2";"ENSG00000117707";"PROX1";"prospero homeobox 1";4378;1,04474914073944;"No"
"row_3";"ENSG00000132376";"INPP5K";"inositol polyphosphate-5-phosphatase K";4381;1,0423731803894;"No"
"row_4";"ENSG00000135250";"SRPK2";"SRSF protein kinase 2";5669;0,688033223152161;"No"
"row_5";"ENSG00000154370";"TRIM11";"tripartite motif containing 11";6363;0,3959139585495;"No"
"row_6";"ENSG00000174720";"LARP7";"La ribonucleoprotein 7, transcriptional regulator";7169;0,206406503915787;"No"
"row_7";"ENSG00000055332";"EIF2AK2";"eukaryotic translation initiation factor 2 alpha kinase 2";7894;0,110498517751694;"No"
"row_8";"ENSG00000129351";"ILF3";"interleukin enhancer binding factor 3";8374;0,0661246106028557;"No"
"row_9";"ENSG00000152242";"ARK2N";"arkadia (RNF111) N-terminal like PKA signaling regulator 2N";8619;0,0507931038737297;"No"
"row_10";"ENSG00000116525";"TRIM62";"tripartite motif containing 62";9247;0,0197986513376236;"No"
"row_11";"ENSG00000124164";"VAPB";"VAMP associated protein B and C";9939;0,00260741962119937;"No"
"row_12";"ENSG00000145901";"TNIP1";"TNFAIP3 interacting protein 1";10243;0,00014572445070371;"No"
"row_13";"ENSG00000080561";"MID2";"midline 2";10441;0;"No"
"row_14";"ENSG00000100298";"APOBEC3H";"apolipoprotein B mRNA editing enzyme catalytic subunit 3H";10515;0;"No"
"row_15";"ENSG00000111335";"OAS2";"2'-5'-oligoadenylate synthetase 2";10696;0;"No"
"row_16";"ENSG00000111732";"AICDA";"activation induced cytidine deaminase";10702;0;"No"
"row_17";"ENSG00000119401";"TRIM32";"tripartite motif containing 32";10794;0;"No"
"row_18";"ENSG00000121236";"TRIM6";"tripartite motif containing 6";10827;0;"No"
"row_19";"ENSG00000124107";"SLPI";"secretory leukocyte peptidase inhibitor";10872;0;"No"
"row_20";"ENSG00000128383";"APOBEC3A";"apolipoprotein B mRNA editing enzyme catalytic subunit 3A";10977;0;"No"
"row_21";"ENSG00000132703";"APCS";"amyloid P component, serum";11061;0;"No"
"row_22";"ENSG00000135114";"OASL";"2'-5'-oligoadenylate synthetase like";11114;0;"No"
"row_23";"ENSG00000138135";"CH25H";"cholesterol 25-hydroxylase";11191;0;"No"
"row_24";"ENSG00000152778";"IFIT5";"interferon induced protein with tetratricopeptide repeats 5";11437;0;"No"
"row_25";"ENSG00000163661";"PTX3";"pentraxin 3";11658;0;"No"
"row_26";"ENSG00000171855";"IFNB1";"interferon beta 1";12062;0;"No"
"row_27";"ENSG00000197110";"IFNL3";"interferon lambda 3";13212;0;"No"
"row_28";"ENSG00000204347";"BTBD17";"BTB domain containing 17";14440;0;"No"
"row_29";"ENSG00000204616";"TRIM31";"tripartite motif containing 31";14482;0;"No"
"row_30";"ENSG00000204977";"TRIM13";"tripartite motif containing 13";14539;0;"No"
"row_31";"ENSG00000232810";"TNF";"tumor necrosis factor";19120;0;"No"
"row_32";"ENSG00000243811";"APOBEC3D";"apolipoprotein B mRNA editing enzyme catalytic subunit 3D";21457;0;"No"
"row_33";"ENSG00000271503";"CCL5";"C-C motif chemokine ligand 5";25797;0;"No"
"row_34";"ENSG00000204713";"TRIM27";"tripartite motif containing 27";29374;-0,018370920792222;"No"
"row_35";"ENSG00000128394";"APOBEC3F";"apolipoprotein B mRNA editing enzyme catalytic subunit 3F";29395;-0,0193025097250938;"No"
"row_36";"ENSG00000102921";"N4BP1";"NEDD4 binding protein 1";29599;-0,0272247511893511;"No"
"row_37";"ENSG00000153560";"UBP1";"upstream binding protein 1";29768;-0,0358776897192001;"No"
"row_38";"ENSG00000130726";"TRIM28";"tripartite motif containing 28";29806;-0,0385042950510979;"No"
"row_39";"ENSG00000105939";"ZC3HAV1";"zinc finger CCCH-type containing, antiviral 1";29929;-0,0459168925881386;"No"
"row_40";"ENSG00000175334";"BANF1";"barrier to autointegration nuclear assembly factor 1";29953;-0,0475410223007202;"No"
"row_41";"ENSG00000185745";"IFIT1";"interferon induced protein with tetratricopeptide repeats 1";29972;-0,0485016703605652;"No"
"row_42";"ENSG00000115415";"STAT1";"signal transducer and activator of transcription 1";30067;-0,0559569038450718;"No"
"row_43";"ENSG00000132109";"TRIM21";"tripartite motif containing 21";30140;-0,0604293532669544;"No"
"row_44";"ENSG00000196262";"PPIA";"peptidylprolyl isomerase A";30369;-0,0773477777838707;"No"
"row_45";"ENSG00000135828";"RNASEL";"ribonuclease L";30696;-0,110540144145489;"No"
"row_46";"ENSG00000171206";"TRIM8";"tripartite motif containing 8";31259;-0,185027629137039;"No"
"row_47";"ENSG00000130813";"SHFL";"shiftless antiviral inhibitor of ribosomal frameshifting";31579;-0,239461794495583;"No"
"row_48";"ENSG00000096063";"SRPK1";"SRSF protein kinase 1";31906;-0,32580378651619;"No"
"row_49";"ENSG00000128016";"ZFP36";"ZFP36 ring finger protein";32131;-0,3882836997509;"No"
"row_50";"ENSG00000163565";"IFI16";"interferon gamma inducible protein 16";32538;-0,554377794265747;"No"
"row_51";"ENSG00000239713";"APOBEC3G";"apolipoprotein B mRNA editing enzyme catalytic subunit 3G";32748;-0,667126059532166;"No"
"row_52";"ENSG00000166801";"FAM111A";"FAM111 trypsin like peptidase A";32867;-0,739545881748199;"No"
"row_53";"ENSG00000124201";"ZNFX1";"zinc finger NFX1-type containing 1";33011;-0,840896844863892;"No"
"row_54";"ENSG00000089127";"OAS1";"2'-5'-oligoadenylate synthetase 1";33440;-1,25012731552124;"No"
"row_55";"ENSG00000088888";"MAVS";"mitochondrial antiviral signaling protein";33739;-1,75303637981415;"No"
"row_56";"ENSG00000172183";"ISG20";"interferon stimulated exonuclease gene 20";34365;-2,70328330993652;"Yes"
"row_57";"ENSG00000244509";"APOBEC3C";"apolipoprotein B mRNA editing enzyme catalytic subunit 3C";34435;-2,92932939529419;"Yes"
"row_58";"ENSG00000186834";"HEXIM1";"HEXIM P-TEFb complex subunit 1";34593;-3,35214519500732;"Yes"
"row_59";"ENSG00000106785";"TRIM14";"tripartite motif containing 14";34844;-4,3317084312439;"Yes"
"row_60";"ENSG00000204435";"CSNK2B";"casein kinase 2 beta";35074;-6,25314235687256;"Yes"
"row_61";"ENSG00000157601";"MX1";"MX dynamin like GTPase 1";35171;-6,65783262252808;"Yes"
"row_62";"ENSG00000185885";"IFITM1";"interferon induced transmembrane protein 1";35202;-7,08682727813721;"Yes"
"row_63";"ENSG00000185201";"IFITM2";"interferon induced transmembrane protein 2";35260;-7,46071910858154;"Yes"
"row_64";"ENSG00000187608";"ISG15";"ISG15 ubiquitin like modifier";35589;-12,6165704727173;"Yes"
"row_65";"ENSG00000115267";"IFIH1";"interferon induced with helicase C domain 1";35613;-13,1369619369507;"Yes"
"row_66";"ENSG00000204610";"TRIM15";"tripartite motif containing 15";35761;-17,1771717071533;"Yes"
"row_67";"ENSG00000067066";"SP100";"SP100 nuclear antigen";35822;-18,7863998413086;"Yes"
"row_68";"ENSG00000165471";"MBL2";"mannose binding lectin 2";35843;-19,53955078125;"Yes"
"row_69";"ENSG00000008517";"IL32";"interleukin 32";36033;-28,3525905609131;"Yes"
"row_70";"ENSG00000142089";"IFITM3";"interferon induced transmembrane protein 3";36100;-31,9207210540771;"Yes"
"row_71";"ENSG00000130303";"BST2";"bone marrow stromal cell antigen 2";36115;-32,9265251159668;"Yes"
"row_72";"ENSG00000111331";"OAS3";"2'-5'-oligoadenylate synthetase 3";36125;-33,4773788452148;"Yes"
"row_73";"ENSG00000179750";"APOBEC3B";"apolipoprotein B mRNA editing enzyme catalytic subunit 3B";36215;-39,8779945373535;"Yes"
"row_74";"ENSG00000188313";"PLSCR1";"phospholipid scramblase 1";36228;-41,2263488769531;"Yes"
"row_75";"ENSG00000149948";"HMGA2";"high mobility group AT-hook 2";36397;-133,276245117188;"Yes"
